217 related articles for article (PubMed ID: 24297151)
1. Circulating melanoma cells in the diagnosis and monitoring of melanoma: an appraisal of clinical potential.
Mumford BS; Robertson GP
Mol Diagn Ther; 2014 Apr; 18(2):175-83. PubMed ID: 24297151
[TBL] [Abstract][Full Text] [Related]
2. Future of circulating tumor cells in the melanoma clinical and research laboratory settings.
De Souza LM; Robertson BM; Robertson GP
Cancer Lett; 2017 Apr; 392():60-70. PubMed ID: 28163189
[TBL] [Abstract][Full Text] [Related]
3. Circulating melanoma cells and survival in metastatic melanoma.
Rao C; Bui T; Connelly M; Doyle G; Karydis I; Middleton MR; Clack G; Malone M; Coumans FA; Terstappen LW
Int J Oncol; 2011 Mar; 38(3):755-60. PubMed ID: 21206975
[TBL] [Abstract][Full Text] [Related]
4. Detection of circulating melanoma cells in the blood of melanoma patients: a preliminary study.
Roland CL; Ross MI; Hall CS; Laubacher B; Upshaw J; Anderson AE; Lucci A
Melanoma Res; 2015 Aug; 25(4):335-41. PubMed ID: 26011119
[TBL] [Abstract][Full Text] [Related]
5. Epithelial-to-Mesenchymal Transition Gene Signature in Circulating Melanoma Cells: Biological and Clinical Relevance.
Rapanotti MC; Cugini E; Campione E; Di Raimondo C; Costanza G; Rossi P; Ferlosio A; Bernardini S; Orlandi A; De Luca A; Bianchi L
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511550
[TBL] [Abstract][Full Text] [Related]
6. Enrichment of circulating melanoma cells (CMCs) using negative selection from patients with metastatic melanoma.
Joshi P; Jacobs B; Derakhshan A; Moore LR; Elson P; Triozzi PL; Borden E; Zborowski M
Oncotarget; 2014 May; 5(9):2450-61. PubMed ID: 24811334
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a multi-marker immunomagnetic enrichment assay for the quantification of circulating melanoma cells.
Freeman JB; Gray ES; Millward M; Pearce R; Ziman M
J Transl Med; 2012 Sep; 10():192. PubMed ID: 22978632
[TBL] [Abstract][Full Text] [Related]
8. MART-1 is expressed less frequently on circulating melanoma cells in patients who develop distant compared with locoregional metastases.
Curry BJ; Myers K; Hersey P
J Clin Oncol; 1999 Aug; 17(8):2562-71. PubMed ID: 10561323
[TBL] [Abstract][Full Text] [Related]
9. Minimal Residual Disease in Melanoma:molecular characterization of in transit cutaneous metastases and Circulating Melanoma Cells recognizes an expression panel potentially related to disease progression.
Rapanotti MC; Viguria TMS; Spallone G; Terrinoni A; Rossi P; Costanza G; Campione E; Lombardo P; Pathirannehalage CD; Orlandi A; Bernardini S; Bianchi L
Cancer Treat Res Commun; 2020; 25():100262. PubMed ID: 33338742
[TBL] [Abstract][Full Text] [Related]
10. The detection of circulating melanoma cells correlates with tumour thickness and ulceration but is not predictive of metastasis for patients with primary melanoma.
Hanekom GS; Stubbings HM; Johnson CA; Kidson SH
Melanoma Res; 1999 Oct; 9(5):465-73. PubMed ID: 10596913
[TBL] [Abstract][Full Text] [Related]
11. Predicting Metastasis in Melanoma by Enumerating Circulating Tumor Cells Using Photoacoustic Flow Cytometry.
Edgar RH; Tarhini A; Sander C; Sanders ME; Cook JL; Viator JA
Lasers Surg Med; 2021 Apr; 53(4):578-586. PubMed ID: 32557708
[TBL] [Abstract][Full Text] [Related]
12. Identification of circulating malignant cells and its correlation with prognostic factors and treatment in uveal melanoma. A prospective longitudinal study.
Callejo SA; Antecka E; Blanco PL; Edelstein C; Burnier MN
Eye (Lond); 2007 Jun; 21(6):752-9. PubMed ID: 16575415
[TBL] [Abstract][Full Text] [Related]
13. Limited genomic heterogeneity of circulating melanoma cells in advanced stage patients.
Ruiz C; Li J; Luttgen MS; Kolatkar A; Kendall JT; Flores E; Topp Z; Samlowski WE; McClay E; Bethel K; Ferrone S; Hicks J; Kuhn P
Phys Biol; 2015 Jan; 12(1):016008. PubMed ID: 25574741
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of circulating melanoma cells detected by reverse transcriptase-polymerase chain reaction.
Palmieri G; Ascierto PA; Perrone F; Satriano SM; Ottaiano A; Daponte A; Napolitano M; Caracò C; Mozzillo N; Melucci MT; Cossu A; Tanda F; Gallo C; Satriano RA; Castello G
J Clin Oncol; 2003 Mar; 21(5):767-73. PubMed ID: 12610172
[TBL] [Abstract][Full Text] [Related]
15. Transcript-Based Detection of Circulating Melanoma Cells.
Morici M; Lin W; Gray ES
Methods Mol Biol; 2021; 2265():235-245. PubMed ID: 33704719
[TBL] [Abstract][Full Text] [Related]
16. Capture and Isolation of Circulating Melanoma Cells Using Photoacoustic Flowmetry.
Edgar RH; Cook J; Douglas M; Samson AP; Viator JA
Methods Mol Biol; 2021; 2265():203-212. PubMed ID: 33704716
[TBL] [Abstract][Full Text] [Related]
17. S100-EPISPOT: A New Tool to Detect Viable Circulating Melanoma Cells.
Cayrefourcq L; De Roeck A; Garcia C; Stoebner PE; Fichel F; Garima F; Perriard F; Daures JP; Meunier L; Alix-Panabières C
Cells; 2019 Jul; 8(7):. PubMed ID: 31330795
[TBL] [Abstract][Full Text] [Related]
18. Detection and isolation of circulating melanoma cells using photoacoustic flowmetry.
O'Brien CM; Rood K; Sengupta S; Gupta SK; DeSouza T; Cook A; Viator JA
J Vis Exp; 2011 Nov; (57):e3559. PubMed ID: 22143421
[TBL] [Abstract][Full Text] [Related]
19. Minimal residual disease in melanoma: circulating melanoma cells and predictive role of MCAM/MUC18/MelCAM/CD146.
Rapanotti MC; Campione E; Spallone G; Orlandi A; Bernardini S; Bianchi L
Cell Death Discov; 2017; 3():17005. PubMed ID: 28280601
[TBL] [Abstract][Full Text] [Related]
20. Circulating tumor cells in the clinical cancer diagnosis.
Zhang P; Zhou H; Lu K; Wang Y; Feng T
Clin Transl Oncol; 2020 Mar; 22(3):279-282. PubMed ID: 31140068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
